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The Medical and Research Services, Veterans Administration Wadsworth Medical Center, and Department of Medicine, University of
Cahfornia, Los Angeles, School of Medicine, Los Angeles, California
Metabolic balance studies and dietary protein requirements in patients
undergoing continuous ambulatory peritoneal dialysis. Balance studies
for nitrogen, potassium, magnesium, phosphorus, and calcium were
carried out in eight men undergoing continuous ambulatory peritoneal
dialysis (CAPD) to determine dietary protein requirements and mineral
balances. Patients were fed high energy diets for 14 to 33 days which
provided either 0.98 (seven studies) or 1.44 g (six studies) of primarily
high biological value protein/kg body wt/day. Mean nitrogen balance
was neutral with the lower protein diet (+0.35 0.83 5EM g/day) and
strongly positive with the higher protein diet (+ 2.94 0.54 g/day). With
the higher protein diet the balances for potassium, magnesium, and
phosphorus were strikingly positive, there was an increase in body
weight in all patients, and a rise in mid-arm muscle circumference in
five of the six patients. The relation between protein intake and nitrogen
balance suggests that the daily protein requirement for clinically stable
CAPD patients should be at least 1.1 g/kg/day; to account for variability
among subjects 1.2 to 1.3 g protein/kg/day is probably preferable.
Potassium balance correlated directly with nitrogen balance (r = 0.81).
High fecal potassium losses (19 1.2 mEq/day) in all patients probably
helped maintain normal serum potassium concentrations. Mean serum
magnesium was increased (3.1 0.1 mg/dl), and magnesium balances
were positive suggesting that the dialysate magnesium of 1.85 mg/dl is
excessive. The net gain of calcium from dialysate was 84 18 mg/day;
this correlated inversely with serum calcium levels (r =
—0.90).
Bilans métaboliques et besoins protéiques alimentaires de malades en
dialyse péritonéale continue ambulatoire. Des etudes de bilan de l'azote,
du potassium, du magnesium, du phosphore et du calcium, étaient fait
en sept hommes en dialyse péritoneale continue ambulatoire (CAPD),
pour determiner leurs besoins protéiques alimentaires et leur bilan
mineral. Les malades ont recu pendant 14 a 33 jours des regimes
hautement energetiques, apportant soit 0,98 (sept etudes), soit 1,44 g
(six etudes) de protéines de haute valeur biologique par kg de poids et
par jour. Le bilan azoté moyen était nul avec le régime comportant Ia
plus faible teneur protéique (+ 0,35 0,88 glj sEM) et était fortement
positive avec le régime a plus forte teneur protéique (+2,94 0,54 g/j).
Avec le régime a haute teneur en proteine, les bilans potassique,
magnCsien et phosphoré étaient fortement positifs; le poids corporel
s'est élevé chez tous les malades; Ia circonférence musculaire mesurée
du milieu du bras a augmente chez cinq sur six malades. La relation
existant entre l'apport protéique et le bilan azoté suggère que les
besoins joumaliers en protéines pour des malades cliniquement stables
en CAPD devraient être au moms de 1,1 g/kg/j; 1,2 a 1,3 g de
protemnes/kglj sont sans doute preférables pour tenir compte de Ia
variabilité entre les sujets. Le bilan potassique était directement corrélé
avec Ia balance azotée (r = 0,81). De fortes pertes potassiques fécales
(19 1,2 mEq/j) chez tous les malades ont probablement contribué a
maintenir normales les concentrations seriques du potassium. La
magnesemie moyenne était élevée (3,1 0,1 mgldl), et les bilans
magnesiens aient positifs suggerant que le magnesium du dialysat (1,85
18 mg/dl) était trop élevé. Le gain net en calcium a partir du dialysat
était de 84 18 mg/j; ce gain était inversement corrélé avec La calcémie
(r = 0,90).
Continuous ambulatory peritoneal dialysis (CAPD) is an
increasingly utilized form of maintenance dialysis therapy [1—31.
Although many clinical and metabolic benefits are ascribed to
CAPD, very little is known about nitrogen and mineral balances
or dietary protein requirements during such treatment. This
problem is of particular relevance because wasting and malnu-
trition occur frequently in patients undergoing other forms of
maintenance dialysis therapy [4—61. It has been suggested that
patients undergoing chronic intermittent peritoneal dialysis are
likely to develop wasting, in part because of the protein losses
during dialysis [7, 8]. The nutritional status of CAPD patients is
not well documented. Many patients seem to gain weight [3].
However, a reduction in total body potassium has been report-
ed in some CAPD patients [91.
The present study was designed to evaluate the dietary
protein requirements and balances for potassium, magnesium,
phosphorus, and calcium in CAPD patients. Studies were
performed under the controlled conditions of a metabolic
balance unit. Thirteen studies were conducted in eight clinically
stable men undergoing CAPD while they ingested two different
high energy, isocaloric diets. Protein intakes averaged either
0.98 g/kg body wt/day, an intake commonly recommended for
patients undergoing maintenance hemodialysis, or 1.44 g pro-
tein/kg body wt/day.
Methods
Thirteen metabolic balance studies were carried out during
CAPD in eight men, aged 27 to 59 years, either at the Special
Diagnostic and Treatment Unit at the Veterans Administration
Wadsworth Medical Center or the Clinical Research Center at
the University of California, Los Angeles, Center for the Health
Sciences. The clinical and nutritional characteristics of the
patients prior to the initial metabolic balance studies and those
in 60 normal male hospital employees who served as controls
are shown in Table 1. Five patients were anuric, while three had
minimal residual renal function. The patients had undergone
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Table 1. Clinical and nutritional characteristics in CAPD patients and in normal male hospital employees
Patient no.
Age
years
Duration
dialysis
months
GFRb Hematocrit
mi/mm vol%
Weight
kg
Relative
body wta
%
Body fata
%
1 52 5
CAPD patients
1.9 24 70.5 98 22.5
2 47 76 0 371 71.2 105 17.0
3 51 17 1.0/0° 38 77.5 108 16.0
4 36 113 0 29 77.5 85 16.0
5 27 7 3.0 27 78.5 99 18.0
6 37 84 0 26 82.5 107 19.5
7 41 65 0 34f 89.8 124 22.0
8 59 27 0 25 75.6 105 16.5
Mean SEM 43.8 3.4 49.3 14 30.0 2.0 77.9 2.2 104 3.9 18.4 0.9
Mean SEM 46.5 1.2 —
Normal hospital employees1
ND ND 79.8 1.5 104 2.0 21.2 0.6
a All data were obtained at the beginning of their first metabolic study.
b GFR was calculated as the mean of creatinine and urea clearance [13].
Methods for measuring the values are described previously [6].
d Includes histidine; tryptophan was not measured by the procedures employed.
a Patient became anuric during the 6-month interval between the two studies.
Indicates patients treated with testosterone.
Indicates race of patient was black.
Indicates race of patient was white.
I Normals were a group of 60 male hospital employees ingesting 115 g protein/day [61.
i Data based on values from nine normal men.
k p < 0.05 from corresponding value for CAPD patients.
'P < 0.01 from corresponding value for CAPD patients.
ND represents data not obtained.
various forms of dialysis for an average of 49 months (range, 5
to 113 months) prior to the evaluation. The duration of treat-
ment with CAPD prior to the initial study varied from 0.5 to 5
months. The average hematocrit was 30 vol%; four patients had
received anabolic steroids prior to the study and continued the
same treatment. The patients' dietary intake prior to each
study, calculated from dietary diaries and recall interviews,
were estimated to provide 1.1 0.1 SEM g protein/kg body
wt/day, and 25.2 2.1 kcal/kg body wt/day. This intake does
not include additional energy derived from glucose absorbed
from peritoneal dialysate. Informed consent was obtained from
each patient.
Methods for estimating relative body weight, skinfold thick-
ness, body fat, and mid-arm muscle circumference have been
described previously [6]. In brief, skinfold thickness was mea-
sured in three locations with a Lange® skinfold caliper; body fat
was calculated from the skinfold values and relative body
weight with the aid of a nomogram [10]. Mid-arm muscle
circumference, an indicator of muscle mass, is the mid-arm
circumference minus subcutaneous fat, measured by triceps
skinfold thickness [11]. Total body potassium was measured
with a whole body potassium counter [12].
In comparison with "normals" of similar age, the CAPD
patients showed no differences in absolute body weight, relative
body weight, body fat, or mid-arm circumferences. Based on
comparison to another group of 18 normal individuals, divided
according to race, two patients had total body potassium that
was below normal, and the value was borderline in three. The
serum levels of total protein, albumin, and transferrin (Table 1)
and C3 (104 5 mg/dl) were each below normal (P < 0.01);
initial values for serum IgG, IgA, 1gM, and C4 were normal.
Plasma concentrations of total essential amino acids were
slightly lower from those in nine normal males ingesting "nor-
mal" protein diets, P < 0.05 (Table 1). Amino acid concentra-
tions at the onset of the two dietary protein studies did not
differ.
Patients were given a constant diet calculated to provide
either 1.0 or 1.4 g proteinlkg body wt/day as shown in Table 2.
Actual protein intake averaged 76 2.1 and 114 1.7 g/day.
The quantity of high biological value protein with each of these
diets was 51 2.6 and 94 2.0 g/day. Five patients were
studied with both diets; three ingested the higher protein diet
first, the other two ingested the alternate sequence. Patients
ingested each diet for two to five days before data collection
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Table 1. (Continued)
Mid-arm
muscle
circumference
cm
Total body
potassium
g/kg
Serum proteins Plasma amino acids
Protein
gidi
Albumin
gIdi
Transferrin
mg/dl
Essential" Nonessential
jimoles/liter
26.1 ND" 5.6
CAPD patients
3.3 136 843 1982
26.4 2.14" 5.9 3.3 167 520 1492
31.1 2.48 6.3 3.7 262 946 2932
22.9 1.37k 5.8 2.8 174 802 2445
24.8 l.80 5.9 3.3 226 1361 2029
30.! 1.78" 6.0 3.8 186 685 1614
29.5 1.4lh 7.2 3.5 283 637 1720
31.1 1.758 6.1 2.9 188 700 1553
27.8 1.1 1.85 0.23s
1.78 0.21"
6.10 0.20 3.32 0.12 203 18 812 91 1971 177
27.1 0.4 2.05 0.06g
1.88 0.04"
Normal hospital employees'
7.38 0.08' 4.98 0.05' 303 5' 1030 40i k 2001 135i
began. The diets provided 2565 68 kcal/day. Fat, carbohy-
drate, and protein provided 47 2.1%, 39 2.2% and 14
0.9%, respectively, of the dietary energy intake. The total
energy intake including glucose absorbed from the peritoneal
dialysate was 3249 82 kcal/day (41.7 1.1 kcal/kg) and did
not differ with the two levels of protein intake. The intake of
deionized water and sodium chloride was varied to maintain
fluid and salt balance. All patients received a daily vitamin
supplement which contained the B vitamins, folic acid, and
ascorbic acid. An average of 7.8 1.0 g/day (range, 3.4 to 15.7)
of aluminum hydroxide gel was consumed.
Metabolic balance studies were carried out as described
elsewhere [14—161. All urine and dialysate outflow collected
over 24-hr periods were refrigerated immediately. Brilliant blue
was given to identify the beginning and end of each 7-day fecal
collection period. Duplicate diets (prepared weekly), rejected
food, emesis, urine collections, dialysate poois, and feces were
each analyzed for nitrogen, potassium, magnesium, phospho-
rus, and calcium. On alternate days, about 35 ml of blood was
obtained by venipuncture before breakfast and after a fast from
the previous evening. Studies were carried out with each diet
for 14 to 33 days (mean, 20).
Daily balances were calculated as the difference between
intake and the sum of fecal, urinary, and dialysate output.
Nitrogen balance was adjusted for changes in body urea nitro-
gen but not for unmeasured losses from skin, respiration, flatus,
and blood sampling. Urea nitrogen appearance, a measure of
net urea production, was calculated according to the following
equation (all in g/day):
Urea nitrogen appearance = urine urea nitrogen + dialysate
urea nitrogen + change in body urea nitrogen.
The changes in body urea nitrogen were calculated as previous-
ly described [17].
CAPD was performed utilizing commercially available 2-liter
bags of dialy sate. The dialysate composition, as reported by the
manufacturer (Baxter-Travenol Laboratories, Deerfield, Illi-
nois), was sodium 132, chloride 102, lactate 35, calcium 3.5, and
magnesium 1.5 (all in mEq/liter), and dextrose either 1.5 or 4.25
g/dl. CAPD was performed as described by Oreopoulos et al
[181. Patients exchanged three to five 2-liter bags during each
24-hr period. The volumes of inflow and outflow dialysate were
calculated from the weight and specific gravity of the dialysate.
The measured dialysate volume instilled averaged 2.06 0.01
liter/bag, and the average daily outflow volume was 10.8 0.49
liter/day (range, 7.7 to 12.9 liter/day). Dialysis clearance was
calculated as follows:
Dialysis clearance (liter/day) =
Dialysate concentration (g/Iiter) x
Volume of dialysate outflow (liter/day)
Plasma concentration (g/liter)
Total clearances for urea and creatinine, the sum of dialysis and
endogenous renal clearances, were 10.7 0.29 liter/day and 9.4
0.52 liter/day, respectively; they did not differ with the two
levels of protein intake (Table 2).
Nitrogen was measured by a modification of the macro-
Kjeldahl technique, potassium by flame photometry, and calci-
um and magnesium by atomic absorption spectrometry. Urea,
creatinine, and phosphorus were measured with a Technicon
Auto Ana1yzer. For measurement of amino acids, I ml of
plasma was deproteinized with 45 mg of sulfosalicylic acid.
Dialysate, collected over one 24-hr period in 12 of the 13
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Table 2. Dietary intakes and characteristics of dialysis patients undergoing CAPD while receiving different protein intakes
1.0 g/kg body wt
Duration
of study
Protein intake Dietary
energy
intake
Total energy intakea CUREA
CCREAT
Totalkcal/kg/ Dialysate Renal Total
Patient days g/day g/kg/day kcal/day kcal/day day liter/day
1 l4b 62 0.88 2604 3l59 44.9 10.3 1.5 11.8 11.6
2 21 68 0.95 12.1 0 12.1 7.1
3 2l' 85 1.09 2413 3341 43.1 10.3 0.9 11.2 11.8
4 21" 84 1.08
14
2682 3692 47.6
79 1.00 2846 3405 43.4
2209 2943 32.8
8 21" 72 0.95 2075 2834 37.5 9.0 0 9.0 7.1
14 79 0.88
6
9.1 0 9.1 8.7
8.0 1.8 9.8 11.3
11.7 0 11.7 9.3
Mean 5EM 18 1.4 76 3.2a 0.98 0.03a 2476 101 3174 122 41.3 1.9 10.07 0.56 — 10.67 0.50 9.56 0.77
aTotal energy intake is the sum of energy from the diet and from glucose absorbed from dialysate. Glucose absorption was measured according
to methods previously described [23].
Indicates initial study. Patients two and three were restudied 5 months later; studies on patients four, five, and seven were done consecutively.
Glucose absorption from dialysate not measured in this patient but was calculated from the equation; glucose absorption (g/liter of dialysate
inflow) = 11.3 (mean dialysate glucose) — 11 [23].
d Four 2-liter bags/day exchanged for the initial 14 days and five 2-liter bags/day for the final 7 days of study.
P < 0.001, by paired t test from corresponding value obtained with 1.4 g/kg protein diet.
Values represent mean SEM of data obtained during entire 14 to 33 days of study.
SEM of seven values on the 1.0 and six values on the 1.4 g/kg protein diets.
studies, and the supernatant from plasma were analyzed with a
Beckman 121 M Amino Acid Analyzer (Beckman Instruments
Corp., Fullerton, California) using a lithium buffer system.
Serum and dialysate total protein was measured by the biuret
method [19]; serum albumin was measured by the brom-cresol
green technique [20]; transferrin, C3, C4, IgG, IgA, and 1gM
were measured with radial immuno-diffusion plates [21]. Prior
to analysis for protein, the dialysate samples were concentrated
200-fold with an Amicon ultrafiltration cell utilizing a PM-b
membrane with a cut off of 10,000 daltons. Recovery studies in
dialysate yielded 101.6 0.4% for nitrogen and 97.5 2.5% for
potassium. Protein intake was calculated by multiplying the
measured dietary nitrogen by 6.25. Dietary energy intake was
calculated from standard food tables [221.
Data on glucose absorption, dialysate protein, amino acid
losses and the fractionation of nitrogen excretion during some
of the metabolic studies have been reported previously [23—26].
Results were analyzed using a BMD computer program [27].
Statistical analysis was performed with the paired I test, linear
regression analysis, and nonlinear regression. Values are ex-
pressed as mean 1 SEM, unless otherwise noted.
Results
Serum chemistries during the study with the two levels of
dietary protein are summarized in Table 3. Serum urea nitrogen
(SUN) averaged 67 50.5 mg/dl with the 1.0 g/kg body wt
protein diet and 91 7.0 mgldl with the 1.4 glkg body wt protein
diet (P < 0.02). Serum creatinine, potassium, calcium, phos-
phorus, magnesium, and bicarbonate did not differ with the two
diets. Although there was some variation in the serum values
during the first week with each diet, these data were generally
quite constant thereafter; for example, after the first week of
study with each diet, the mean coefficient of variation for SUN
in all patients was 5.6% (range, 1.4 to 11.8%).
The nitrogen balance data are shown in Table 4 and Figure 1.
With the higher protein diet, fecal nitrogen, total nitrogen
output, and urea nitrogen appearance were each significantly
greater than with the lower protein diet. In the four studies in
patients who were excreting urine, the urinary nitrogen varied
from 1.0 to 2.6 g/day or 8.9 to 20.0% of total nitrogen output.
Dialysate was the principle source of nitrogen loss, accounting
for 88% of total nitrogen output in the patients with no urine
output. Urea was the major nitrogenous component in dialysate
and comprised 67 2.9% and 74.4 2.4% of total dialysate
nitrogen with the lower and higher protein diets, respectively.
Losses of total protein and amino acids into dialysate did not
differ with the two diets; the mean values for these constituents
in dialysate were 9.2 0.6 and 3.3 0.4 g/24 hr, respectively.
Thus, total nitrogen from protein and amino acids accounted for
21 3.9% of total dialysate nitrogen with the lower protein diet
and 17 1.6% of dialysate nitrogen with the higher protein diet.
Overall nitrogen balance, adjusted for changes in body urea
nitrogen but not for unmeasured losses, was +0.35 0.83 g/day
with the 1.0 g/kg protein diet and + 2.94 0.54 g/day with the
1.4 glkg diet; only the latter value was significantly greater than
zero (P < 0.001) (Table 4). Nitrogen balance was somewhat
5
2502 2847 40.0
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Table 2. (Continued)
1.4 glkg body wt
Protein intake Dietary
energy
intake
giday g/kg/day kcal/day
Total energy intakea CUREA
Dialysate Renal Total
kcal/day kcallkg/day liter/day
2lb 111
21" 116 1.41
1.43 2865 3461
21" 119 1.37 2817
3252
3509 39.1
23 2.0 114 1.7 1.44 0.02 2670 74 3336 106
7.7 3.3 11.0 12.1
9.7/IO.4 0 9.7/10.4 6.5/7.1
11.4
more positive with the higher protein diet than with the lower
protein diet, but this did not reach significance; paired t test (P
= 0.06). For the individual patients studied on both diets, the
balances were significantly greater with the higher protein diet
(P < 0.01) for four of the five patients; for the fifth patient (case
3 in Table 4), the balances did not differ.
The relationship between nitrogen and protein intake is
shown in Figure 2. When the studies with the high and low
protein diets were analyzed together, the relationship between
nitrogen balance and protein intake was curvilinear; there was
no further increment in nitrogen balance above a protein intake
of 1.09 g/kg/day. Dietary potassium, magnesium, phosphorus,
and calcium each varied directly with nitrogen intake (Tables 4
to8and Fig. 1).
The results for potassium balance are shown in Table S and
Fig. 1. Dietary potassium intake averaged 64 mEq/day with the
lower protein diet and 84 mEq/day with the higher protein
intake. Serum potassium averaged 4.3 0.2 mEq/liter with
both diets combined, and dialysate potassium losses correlated
with the serum levels (r = 0.74, P < 0.01). A striking feature
was the loss of 17 to 31% of dietary potassium in the stool, with
a loss of 16.9 1.1 mEq/day with the low protein diet and 20.4
2.1 mEq/day with the high protein diet. Fecal potassium
losses correlated with dietary potassium intake (r = 0.61; P <
0.05) but not with serum potassium levels. Net potassium
absorption (dietary intake minus fecal losses) correlated with
potassium intake; r = 0.97, P < 0.001. Potassium balance was
neutral with the 1.0 g/kg diet (+6.8 4.6 mEq/day) and
significantly greater than zero with the 1.4 g/kg diet; + 17.8
4.0 mEqiday, P < 0.01. Potassium balance correlated direct-
ly with the dietary intake of potassium: Potassium balance
(mEq/day) equals 0.64 diet intake (mEq/day) minus 35; r =0.80,
P < 0.01; potassium balance also correlated with nitrogen
balance; r = 0.81, P < 0.001.
The results for magnesium balance during 12 studies are
shown in Table 6 and Figure 1. The concentration of magnesium
measured in several different lots of dialysate was 1.85 0.003
mg/dl, and serum magnesium levels were 3.1 0.1 mg/dl with
both diets (normal range for serum magnesium, 1.6 to 2.7
mg/dl). There was a net loss of magnesium into dialysate in all
studies but one. The quantity of magnesium removed in the
dialysate averaged 46 7.5 mg/day and correlated with the
serum magnesium concentrations; r = 0.88, P < 0.01. In all but
one study, the patients exhibited neutral or positive magnesium
balances, and the mean magnesium balance was slightly greater
when patients ingested the high protein diets than with the
lower protein diets; P < 0.05. Magnesium balance correlated
inversely with fecal loss; r = 0.70, P < 0.02. Net magnesium
absorption (dietary intake minus fecal losses) ranged from 74 to
200mg during 11 studies, a single patient (case 6) exhibited high
fecal losses of magnesium and calcium and negative net absorp-
tion of these minerals (Tables 7 and 8 and Fig. 1). The relation-
ship between dietary magnesium intake and net magnesium
absorption is shown in Figure 3; these data are shown in
relation to previously published data in patients with chronic
uremia [16, 28, 29].
The data for phosphorus balance are shown in Table 7 and
Figure 1. Dietary phosphorus intake was substantially greater
with the high protein diet due to the greater intake of dairy
products. There was a positive correlation between the balance
for phosphorus and that for potassium; r = 0.64, P < 0.05. In
the patients eating both diets, the increment in phosphorus
balance correlated with the change in phosphorus intake: r =
0.93, P < 0.05. Despite the ingestion of 7.8 1.0 g/day of
aluminum hydroxide, net phosphorus absorption was related to
phosphorus intake: r = 0.87, P < 0.001. The relationship
between net absorption of phosphorus and dietary phosphorus
intake is shown in Figure 4. The observations for the patients
treated with CAPD fell along the same regression slope seen in
patients with chronic uremia [16, 30, 31].
The results for calcium balance are shown in Table 8 and
Figure 1. The concentration of calcium in dialysate was 6.9
0.03 mgldl. Total serum calcium averaged 9.0 0.3 mg/dl
during all 13 studies. Net calcium uptake from dialysate aver-
Duration
of study
days
CCREAT
Total
21' 108 1.44 2483 2870 40.3 11.8 0 11.8 8.4
21 116 1.52 2773 3330 43.0 10.2 0 10.2 8.7
33 117 1.44 2430 3596 46.4 10.6 0 10.6 9.6
44.1
2650
11.4
10.27 0.5942.1 1.2
0 9.3
— 10.82 0.29 9.13 0.72
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ND = Data not obtained.
Fig. 1. Nitrogen, potassium, magnesium, phosphorus, and calcium
balances for 13 studies in eight men undergoing CAPD. The seven
balances represented on the left of the figure illustrate data obtained
during ingestion of the 1.0 g protein/kg/day diet; the six balances on the
right of the figure are from data obtained with the 1.4 g protein/kg/day
diet. Data from each study are shown vertically above the patient
number. Values represent the mean of data obtained during the entire
14 to 33 days of study. Intake is plotted down from the zero line; outputs
are plotted up from the line indicating the intake 1141. The black area
represents fecal losses, the dotted area, urinary output, and the
crosshatched area, dialysate losses. Nitrogen and mineral balances are
represented as mean 1 SEM [1]. For the nitrogen balance, the
interrupted lines indicate the balance adjusted for estimated changes in
body urea pool [17]. ND represents data not obtained.
0
ND
300
600
0
1200
2400
I
Patient no. 1 2 3 4 5 7 8 2 3 4 5 6 7
aged 84 18 mg/day and correlated inversely with serum
calcium: Net uptake equals 600 minus 58 (serum calcium,
mgldl); r =
—0.90, P < 0.001. Dietary calcium intake was
significantly greater with the higher than the lower protein diet.
During nine of the 12 studies there was a positive calcium
balance (>85 mg/day); the mean calcium balance was slightly
greater with the high than the low protein diet, P < 0.05. When
patient six is excluded, both overall calcium balance and net
calcium absorption correlated with dietary calcium intake; r =
0.74, P < 0.01 and r = 0.64, P < 0.05, respectively. The
relationship between net calcium absorption and dietary calci-
um intake is shown in Figure 5; these data are superimposed on
observations previously reported in patients with chronic ure-
mia [16, 28, 30, 31]. There is a direct correlation between serum
calcium levels and net calcium absorption when the data from
patient six is excluded: r = 0.73, P < 0.01. Overall calcium
balance correlated with magnesium balance, r 0.84, p <
0.001; the change in calcium balance as patients who received
Table 3. Serum chemistries in patients undergoing CAPD while receiving different protein intakes
1.0 g/kg body wt
Urea
Nitrogen
—
Creatinine
.Potassium
mEqiliter
Calcium Phosphorus Magnesium .Bicarbonate
mEqilitermg/dlPatient no. mg/dl
1 65 4.0 10.0 0.15 3.6 0.26 10.2 0.22 4.4 0.31 ND 27.8 0.63
2 74 3.8 19.2 0.31 3.8 0.15 9.0 0.06 5.0 0.11 3.4 0.07 17.8 0.55
3 40 1.3 14.2 0.17 4.0 0.05 7.9 0.19 3.3 0.15 3.1 0.15 29.3 0.63
4 62 1.0 13.3 0.14 3.9 0.06 8.6 0.14 5.1 0.09 3.0 0.07 23.7 0.64
5 71 2.2 14.8 0.32 4.2 0.17 10.8 0.13 5.0 0.28 3.0 0.07 28.2 1.08
6
7 88 2.1 15.9 0.13 5.1 0.11 7.4 0.09 5.1 0.14 3.2 0.15 18.4 0.61
8 72 1.0 18.5 0.18 3.7 0.07 8.3 0.06 3.8 0.10 2.7 0.10 23.7 0.46
Mean 5EM" 67 5.5 15.1 1.2 4.0 0.19 8.9 0.46 4.5 0.27 3.1 0.10 24.1 1.76
Values represent mean 5EM of data obtained during entire 14 to 33 days of study.
a Only a single measurement was obtained after 2 weeks of study.
b SCM of seven values on the 1.0 and six values on the 1.4 glkg protein diets.
I
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Table 3. (Continued)
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1.4 glkg body wt
Urea
Nitrogen Creatinine .Potassium
mEqiliter
Calcium Phosphorus Magnesium .Bicarbonate
mEqilitermg/dlmg/dl
77 1.3 14.8 0.23 4.0 0.10 8.7 0.12 4.7 0.03 3.l 23.8 0.40
100 3.4 21.7 0.47 4.6 0.13 8.9 0.09 3.5 0.27 3.5 0.05 23.1 0.76
76 1.5 12.9 0.09 4.0 0.12 9.1 0.09 4.6 0.16 3.3 0.07 24.7 0.58
78 1.2 13.7 0.11 3.8 0.12 10.2 0.14 6.4 0.11 2.6 0.05 23.3 0.68
118 4.2 19.3 0.45 5.3 0.10 9.7 0.15 5.6 0.10 2.7 0.05 21.8 0.59
99 2.2 15.8 0.10 5.6 0.13 8.5 0.25 4.0 0.35 3.3 0.13 20.8 0.42
91 7.0 16.4 1.40 4.6 0.31 9.2 0.26 4.8 0.43 3.1 0.15 22.9 0.57
Fig. 2. Relationship between the dietary protein intake and the nitrogen
balance during 13 studies in eight men undergoing CAPD. Each circle
represents the mean of data obtained during the 14 to 33 days of study.
The calculated relationship between protein intake and nitrogen bal-
ance, indicated by the curved line, is as follows: Nitrogen balance =
_27935e_972r0tn rntak) + 3.05.
//////I' I I
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Magnesium intake, mg/day
Fig. 3. Relationship between dietary magnesium intake and net magne-
sium absorption. Data for 11 studies in patients undergoing CAPD are
indicated by the crossed lines (X). Values represent the mean data
obtained from the 14 to 33 days of study. The heavy solid line depicts
the regression analysis, y = 0.40 X +8.1, r = 0.61, P < 0.05. Data are
not available for patient 1; the data from patient 6 who had abnormally
high fecal magnesium losses are omitted from these calculations. For
comparison, magnesium absorption data from 24 studies in 16 nondia-
lyzed chronic uremic patients are shown [16, 28]; the thin solid line
indicates the regression analysis for these data and the interrupted lines
represent the 95% confidence limits.
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both diets went from one diet to another correlated with the
change in phosphorus balance; r = 0.88, P < 0.05.
Assessment of various nutritional parameters was performed
before and after each study. There was no change in anthropo-
metric measurements during ingestion of the low protein diet.
During ingestion of the high protein diet there was a significant
increase in body weight, P < 0.02 (Fig. 6). Also mid-arm muscle
circumference increased in five of the six patients, and the sum
of the triceps and subscapular skinfold thickness, an indicator
of body fat, rose in four of these patients; these changes were
not significant when the six patients were analyzed together.
There were no changes in the serum levels of any protein during
these short periods of treatment with either diet. The plasma
amino acid concentrations did not change; moreover, there
were no differences in plasma amino acid levels between the
two diets.
Discussion
The present results indicate that in men undergoing CAPD,
nitrogen balance is near neutral (+0.35 0.83 g/day) when they
ingest approximately 1.0 g protein/kg body wt/day and is
significantly positive (+ 2.94 0.54 g/day) with an intake of 1.4
g/kg/day. When balances are adjusted by about 0.4 g nitrogen!
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Table 4. Nitrogen intake, output, and adjusted balance and urea nitrogen appearance all in gN/day in patients undergoing CAPD while
receiving different protein intakes
Diet, 1.0 glkg body wt
Patient no. Diet Dialysate Urine Stool
Total
nitrogen
output
Urea
nitrogen
appearance
Adjustedd
balance
1 9.90 9.64 0.41 1.37 1.34 12.35 0.43 7.52 0.64 —2.55 0.66
2 10.84 11.02 0.35 — 1.50 12.48 0.29 7.93 0.48 —0.97 0.34
3 13.53 8.29 0.10 0.97 1.61 10.87 0.18 4.63 0.14 +3.02 0.28
4 13.45 9.24 0.15 — 1.88 11.12 0.13 5.62 0.32 +2.51 0.24
5 12.50 8.12 0.31 1.72 1.68 11.51 0.31 5.95 0.39 +1.60 0.27
6
7 12.66 13.06 0.31 — 1.90 14.95 0.27 8.94 0.46 —1.96 0.31
8 11.54 9.25 0.07 — 1.34 10.66 0.07 6.12 0.18 +0.80 0.13
Mean SEM 12.06 0.5l' 9.80 0.65 — 1.61 0.09a 11.99 0.56b 6.67 0.57" +0.35 0.83
Values represent mean or mean SEM of data obtained during entire 14 to 33 days of study. N represents nitrogen.
P < 0.05, by paired t test from corresponding values obtained with 1.4 g/kg protein diet.
bP < 0.02, by paired t test from corresponding values obtained with 1.4 g/kg protein diet.
P < 0.001, by paired t test from corresponding values obtained with 1.4 g/kg protein diet.
d Nitrogen balance adjusted for change in body urea nitrogen pool but not for blood drawing or insensible losses.
5EM of seven values on the 1.0 and six values on the 1.4 g/kg protein diets.
N balance is significantly greater with the higher than lower protein diet (P < 0.01).
Fig. 4. Relationship between dieta,y phosphorus intake and net phos-
phorus absorption. Data for 13 studies in patients undergoing CAPD are
indicated by the crossed lines (X). The heavy solid line depicts the
regression analysis, y = 0.70 X +207, r = 0.87, P < 0.001. For
comparison, phosphorus absorption data from 33 studies in 19 nondia-
lyzed chronic uremic patients are shown [16, 30, 31]. The thin solid line
represents the regression analysis for these data, and the interrupted
lines represent the 95% confidence limits.
day for unmeasured losses from skin, respiration, and flatus
[32], and by an additional 0.4 g nitrogen/day for blood sampling,
balances would be somewhat more negative. Even with adjust-
ment for these unmeasured nitrogen losses, nitrogen balance
was still strongly positive with the 1.4 g/kg protein diet. Other
data which support an anabolic effect of the higher protein diet
are the direct correlation between nitrogen balance and potassi-
um balance and the significantly positive phosphorus and
magnesium balances with the higher protein diet. Moreover,
with the higher protein diet, body weight rose significantly, and
mid-arm muscle circumference increased in five of the six
patients. The observation that serum proteins did not increase
during the study may reflect the relatively short duration of the
study, the losses of proteins into dialysate, and/or metabolic
derangements in protein metabolism caused by uremia, itself.
In earlier studies, nitrogen balances were reported to be
strongly positive in patients undergoing maintenance hemodial-
ysis and receiving high calorie diets which provided 1.25 to 1.62
g of primarily high quality protein/kg body wt/day [33—36].
More recently, Borah et a! reported substantially less positive
nitrogen balances in four patients who received diets providing
1.38 g protein/kg body wt/day (range 1.21 to 1.47) and under-
went hemodialysis three times weekly using modern dialysis
techniques [37]. The average nitrogen balance in their patients
was +0.03 to +2.57 g/day (grand mean, + 1.06 0.59 glday). If
adjustment is made for unmeasured nitrogen losses from skin,
respiration, flatus, and blood drawing, two of the four patients
would be in negative balance.
Several factors may account for the positive nitrogen bal-
ances in our CAPD patients who received the 1.44 g/kg protein
diet. First, the total energy intake from food and glucose
absorbed from dialysate was high, averaging 42 1.2 kcal/kg
body wt/day (Table 2): This compares with an energy intake of
27 1.5 kcallkg/day in the hemodialysis patients of Borah et al.
The CAPD patients were sedentary during the metabolic stud-
ies, a factor which might have reduced their energy expendi-
x
x
x
XX
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Table 4. (Continued)
Diet, L4 g/kg body wt
Diet
Total Urea
nitrogen nitrogen Adjusted
Dialysate Urine Stool output appearance balance
17.29 12.42 0.12 — 1.70 14.12 0.12 9.6 0.26 +2.84 0.30
18.58 13.92 0.31 — 1.87 15.80 0.34 10.9 0.29 +2.16 0.39
18.65 11.60 0.14 — 2.06 13.66 0.17 8.52 0.29 +4.44 0.20
17.79 8.77 0.20 2.61 1.67 13.02 0.26 8.90 0.44 +4.66 0.37
18.50 14.48 — 1.54 16.02±0.22 13.09±0.86 +1.66±0.47
19,09 14.80 0.23 — 1.98 16.79 0.26 11.46 0.20 +1.86 0.l9
18.32 0.27 12.67 0.93 — 1.80 0.08 14.90 0.61 10.42 0.71 +2.94 0.54
Table 5. Potassium intake, output and balance in patients undergoing CAPD while receiving different protein intakes
1.0 g/kg body wt 1.4 g/kg body wt
Patient no, Diet Dialysate Urine Feces Balance Diet Dialysate Urine Feces Balance
1
mEqiday
60.7 35.3 0.6 11.6 18.8 —5.0 2.4
2 52.8 42.9 0.8 — 16.3 —6.4 0.8 90.5 46.7 0.5 — 25.8 + 18.1 2.2
3 71.6 35.9 0.8 2.7 17.2 + 15.7 1.7 89.8 43.5 0.7 — 22.4 +23.9 3.5
4 71.1 34.2 0.4 — 22.1 + 14.7 0.5 89.4 44.2 1.0 — 16.0 +29.2 2.4
5 81.3 32.7 1.2 11.2 13,5 +23.9 1.4 66.8 28.7 0.8 8.7 14.9 +14.5 0.9
6 71.0 53.0 0.8 — 17.2 +0.8 1.1
7 57.8 48.1 0.8 — 14.6 —4.9 1.3 97.0 50.7 0.6 — 26.2 +20.0 1.1
8 52.4 26.8 0.9 — 16.0 +9.6 1.3
Mean SEM 64.0 4.lb 36.6 2.6 — 16.9 1.1 +6.8 4.6 84.1 5.0 44.5 3.5 — 20.4 2.1 +17.8 4.0
Values represent mean or mean SEM of data obtained during the entire 14 to 33 days of study.
These figures are the SEM of seven values on the 1.0 and six values on the 1.4 g/kg protein diets.
b P < 0.01, by nonpaired ttest from corresponding value obtained with 1.4 glkg diet.
ture, but the same factor was probably operative for the
hemodialysis patients undergoing balance studies. Second, the
glucose absorbed from peritoneal dialysate may have had an
anabolic effect by stimulating insulin secretion and lowering
serum glucagon [38]. This effect on insulin secretion may have
been continuous because dialysate glucose is greater than
plasma glucose throughout the dialysis cycle. Nitrogen balance
was substantially more negative on the days that the patients of
Borah et al underwent hemodialysis; it is possible that various
factors related to hemodialysis, per se, may have promoted
negative balance [39, 40]. It is also possible that the greater
removal of toxic "middle molecules" may also contribute to the
anabolic effect of CAPD [1].
At the onset of these studies, the anthropometric values in
the CAPD patients were not different from normal (Table 1)
although the serum total protein, albumin and transferrin con-
centrations were slightly below normal. However, the serum
proteins were no different from those in typical patients under-
going hemodialysis [5, 6]. Because these patients were not
severely wasted, it is unlikely that the improvement in nutri
tional status with the 1.4 glkg protein diet was due to the
exaggerated nutritional improvement which may occur when
malnourished patients are fed a nutritious diet [41].
The results of the present study provide data concerning the
dietary protein requirements during CAPD. Inspection of Fig-
ure 2 indicates that with a dietary protein intake above 1.09
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Table 6. Magnesium intake, output and balance in patients undergoing CAPD while receiving different protein intakes
1.0 gIkg body wt 1.4 g1kg body wt
Patient no. Diet
Neta
dialysate loss Urine Feces Balance Diet
Nets
dialysate loss Urine Feces Balance
2 203 54 2 — 96
mg/day
+53 8 318 51 3 — 228 +38 7
3 277 74 5 12 177 +14 7 317 67 2 — 170 +80 16
4 293 54 2 — 167 +72 4 347 73 3 — 147 +127 5
5 347 38 4 31 252 +26 35 295 6 1 40 147 +102 10
6 288 9 3 — 337 —58 10
7 253 3 5 — 152 +38 6 355 58 3 — 189 +108 18
8 179 2 6 — 105 +75 7
Mean SEMb 259 25 48 10 — 158 23 +46 l0 320 11 44 12 — 203 30 +66 28
Values represent mean or mean SEM of data obtained during the entire 14 to 33 days of study.
Magnesium and calcium balance studies were not performed in patient 1.
a Net dialysate loss represents the total inflow magnesium less total effluent magnesium.
b These figures are the SEM of six values on the 1.0 and six values on the 1.4 glkg protein diet.
P < 0.05, by paired t test from corresponding values obtained with 1.4 glkg protein diet.
Calcium intake, mg/day
Fig. 5. Relationship between dietary calcium intake and net calcium
absorption. Data for 11 studies in patients undergoing CAPD are
indicated by the crossed lines (X). The heavy solid line indicates the
regression analysis, y = 0.42 x —277, r = 0.64, P < 0.05. Data are not
available for patient 1; data from patient 6 with abnormally high fecal
losses are omitted from calculations, as are the data obtained during the
last 12 days of study in patient 4 when he was treated with 1,25
dihydroxycholecalciferol. For comparison, calcium absorption data
from 41 studies in 27 nondialyzed chronic uremic patients are shown
116, 28, 30, 311. The thin solid line indicates the regression analysis for
these data and the interrupted lines represent the 95% confidence limits.
glkg/day, there was no further increment in nitrogen balance
with greater protein intake. These observations suggest that the
daily protein requirement for clinically stable patients undergo-
Skin-fold
tricep + subscapular.
mm
Fig. 6. Change in body weight, mid-arm muscle circumference, and
ski nfold thickness during studies in six men ingesting 1.4 g protein/kg
body WI dietfor 21 to 33 days. Each circle indicates the change in the
value obtained at the termination of the study in a given patient
compared to the measurement obtained at the onset of the study (Table
I). The bars represent the mean increment in values during the course
of the six studies. The increment in body weight was significant (P <
0.02).
ing CAPD is at least 1.1 g/kg/day. The requirement for protein
during CAPD is probably nearer to 1.2 to 1.3 g protein/kg body
wt/day based on considerations to account for variability among
subjects in the calculation of Recommended Dietary Allow-
ances [421. These recommendations are consistent with a report
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Table 7. Phosphorus intake, output, and balance in patients undergoing CAPD while receiving different protein intakes
1.0 g/kg body wt 1.4 g/kg body wt
Patient no. Diet Dialysate Urine Feces Balance Diet Dialysate Urine Feces Balance
mg/day
922 327 10 81 588 —73 53
2 979 214 11 — 452 +314 17 1673 288 9 — 988 +399 56
3 1118 283 14 16 632 +188 42 1689 259 16 — 930 +500 87
4 1036 402 7 — 483 +151 11 2069 443 8 — 710 +914 56
5 1192 326 11 103 189 +574 45 1957 430 11 223 588 +718 20
6 1709 334 7 — 1000 +375 46
7 964 377 13 — 478 +109 24 2395 236 28 — 819 + 1340 69
8 1117 336 20 — 456 +325 40
Mean SEMa 1047 37" 324 23 — 468 53" +227 77 1915 117 332 36 — 839 67 +708 152
Values represent mean or mean SEM ofdata obtained during the entire 14 to 33 days of study.
'These figures are the SEM of seven values on the 1.0 and six values on the 1.4 g/kg protein diets.
P < 0.01, by paired I test from corresponding values obtained with the 1.4 g/kg diet.
Table 8. Calcium intake, output and balance in patients undergoing CAPD while receiving different protein intakes
1.0 g/kg body wt 1.4 g/kg body wt
Net dialysate Net dialysate
Patient no. Diet uptake' Urine Feces Balance Diet uptake Urine Feces Balance
mg/day
2 718 76 7 — 688 +126 56 1186 139 10 — 1166 +158 23
3 1035 134 14 2 1130 +37 37 1076 72 6 — 827 +320 75
4 605 77 3 — 696 —14 15 1532 46 4 — 1198 +379 42b
5 837 —22 7 17 452 +348 22 1211 3 4 33 644 +537 48
6 1340 74 14 — 2146 —731 76
7 870 190 14 — 969 +90 14 1791 68 12 —. 1336 +523 137
8 546 146 17 — 605 +86 41
Mean 5EMC 769 74d 100 30 — 753 110 +112 51d 1356 108 67 18 — 1220 213 +198 194
Values represent mean or mean SEM of data obtained during the entire 14 to 33 days of study.
'Net dialysate uptake represents the total inflow calcium less total calcium in effluent dialysate.
Received 0.25 g 1,25 dihydroxycholecalciferol during the last 12 days of the study.
These figures are the SEM of six va'ues on the 1.0 and six values on the 1.4 g/kg protein diets.
' P < 0.05 by paired t test from corresponding values obtained with 1.4 g/kg protein diet.
of neutral or positive balance in seven of eight patients undergo-
ing CAPD and fed 1.2 g protein/kg/day [43]. A daily protein
intake above 1.2 to 1.3 g protein/kg/day might be indicated for
wasted patients, those receiving less energy, and those with
intercurrent illnesses, particularly peritonitis during which pen-
toneal losses of protein are increased [241. For an obese
individual, protein intake probably should be calculated for
normal body weight adjusted for age, height, and sex.
The findings of the present study (Table 4) also indicate that
in CAPD patients the SUN concentrations are rather low. Thus,
despite the high protein intake of 108 to 119 g/day with the 1.4
glkg/day diet, the SUN was only 91.3 7.0 mg/dl; with the 1.0
g/kg diet which provided 62 to 85 g/day of protein, the mean
SUN was even lower, 67.4 5.5 mg/dl. These relatively low
SUN levels with CAPD were due to a low urea nitrogen
appearance (Table 4), which comprises a smaller fraction of
total nitrogen output than in normal individuals or hemodialysis
patients eating similar amounts of protein. The low urea nitro-
gen appearance in the CAPD patients is probably due to the
quantity of protein, amino acids, and peptides lost in dialysate
[26] as well as the positive nitrogen balance.
Serum potassium levels were normal or in the lower range of
normal in most patients. These findings were present despite
the rather high potassium intake, particularly with the higher
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protein diet. The relatively low serum potassium levels were
not due to a high peritoneal clearance of potassium which was
65 2.5 liters/week; this level is lower than our calculated
values of 80 to 90 liters/week for potassium dialysance during
hemodialysis carried out with a dialysate potassium of 2.0
mEqlliter for 4 hr thrice weekly. The low serum potassium
appears to be related to the anabolic state and positive balance
in many of the patients and to the high fecal potassium losses.
Fecal potassium excretion was 19 1.2 mEq/day or 26 1.3%
of dietary intake, a percentage greater than the reported value
of 15 1.1% in individuals with normal renal function [44]. The
percent loss was similar to the 30% reported in nondialyzed
chronically uremic patients [15, 45] and the 37% in those
undergoing twice-weekly hemodialysis [45]. However, serum
potassium levels were generally lower in the CAPD patients
than in the uremic patients [15]. The reasons for the increased
fecal potassium losses in renal failure have been studied in
experimental animals [46, 471; increased activity of Na-K-
ATPase and enhanced sodium absorption and potassium excre-
tion were found in the colon of rats with renal insufficiency and
fed high potassium intakes.
For individuals with normal renal function, potassium and
nitrogen are found in a constant ratio in soft tissue, and the
relative magnitudes of gain or loss of these two elements during
balance studies are similar to their ratio in soft tissue. The
reported ratio for loss of potassium (mEq) to that of nitrogen (g)
is 3.0: 1.0 during fasting [14]. The ratios of potassiumlnitrogen
were higher in the present studies; thus, the ratio of potassium
balances to those of nitrogen averaged 6.7: 1.0, (Tables 4 and 5
and Fig. 1), and the slope between potassium and nitrogen
balances was 4.4. The ratio averaged 8.0:1.0 after the balances
were adjusted for unmeasured losses of 0.8 g/day for nitrogen
(vide supra) and 2 mEq/day for potassium [48]. The higher
ratios of potassium to nitrogen and the great variance of the
ratio in the CAPD patients may reflect a greater and more
variable depletion of soft tissue stores of potassium in dialysis
patients [49, 50].
Dietary potassium intake varied according to protein intake
and therefore was not an independent variable. Also, potassium
balance correlated with nitrogen balance. For this reason, no
conclusion can be reached regarding dietary potassium
requirements.
The value for net magnesium removed during peritoneal
dialysis, 46 8 mg/day, is greater than that reported by Parker
and Nolph [511; this difference probably is related to higher
serum magnesium levels in the present study. With the excep-
tion of patient six, net intestinal absorption of magnesium was
positive and the fraction of net absorption was similar to that
reported in patients with stable chronic renal failure [16, 28].
The presence of normal net intestinal absorption of magnesium
in most patients and the use of a dialysate magnesium concen-
tration of 1.85 mg/dl probably accounts for the high serum
magnesium levels in the CAPD patients. The lower serum levels
reported elsewhere may have arisen because of lower dietary
magnesium intake [51]. A reduction in the dialysate concentra-
tion of magnesium to 1.2 to 1.5 mg/dl (1.0 to 1.2 mEq/liter)
might result in serum magnesium concentrations that are closer
to normal.
It has been claimed that hyperphosphatemia may be prevent-
ed more easily in uremic patients undergoing CAPD than in
those treated with hemodialysis [3]. The present report does not
support this contention because the average serum phosphorus
concentrations were 5.0 mg/dl or above during six of the 13
studies. The dietary phosphorus intake was high in the CAPD
studies, averaging 1.0 and 1.9 g/day with the low and high
protein diets. Despite the ingestion of substantial quantities of
aluminum hydroxide by the CAPD patients; net phosphorus
absorption was similar or greater than that in nondialyzed
uremic patients who were not receiving phosphate binders (Fig.
4). Thus, the effects of the phosphate-binding antacids are
largely offset by the high phosphate diet ingested by some
CAPD patients.
Net absorption of calcium (dietary intake minus fecal losses)
exceeded 200 mg/day in five of nine studies with the patients
eating more than 800 mg of calcium/day (Table 8 and Fig. 5).
Net calcium absorption was high in these patients compared to
uremic patients ingesting similar quantities of calcium. The net
calcium transfer from peritoneal dialysate was 84 18 mg/day,
a value greater than that extrapolated from the data of Parker
and Nolph [51]. The net calcium transfer from dialysate was
correlated inversely with serum calcium levels. The observa-
tion of high net dietary absorption and dialysate absorption of
calcium in a substantial number of patients undergoing CAPD
raises the possibility that such treatment could lead to contin-
ued calcium accumulation with a propensity towards hypercal-
cemia; indeed, a preliminary report suggests that mild hypercal-
cemia developed in a substantial fraction of patients treated
with CAPD [52].
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